Synopsis
Synopsis
0
VMF
0
FDF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 4-(2-(di-n-propylamino)ethyl)-2(3h)-indolone
2. Requip
3. Ropinirol
4. Ropinirole
5. Sk And F 101468
6. Sk And F-101,468
7. Skf 101468
1. 91374-20-8
2. Ropinirole Hcl
3. Requip
4. 4-(2-(dipropylamino)ethyl)indolin-2-one Hydrochloride
5. Skf 101468 Hydrochloride
6. Requip Xl
7. Sk&f 101468-a
8. Ropinirole (hydrochloride)
9. 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one;hydrochloride
10. D7zd41rzi9
11. Ropinirole (as Hydrochloride)
12. 4-(2-(dipropylamino)ethyl)-2-indolinone Monohydrochloride
13. 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2h-indol-2-one Hydrochloride
14. Sk&f-101468a
15. Sk&f-101468-a
16. Ropinirolhydrochloride
17. Ropinirolehydrochloride
18. Ropinirole Hydrochloride [usan]
19. Sr-01000076215
20. Ropinirole Hydrochloride [usan:usp]
21. Unii-d7zd41rzi9
22. C16h24n2o.hcl
23. Adartrel
24. Repreve
25. Requi
26. Requip Cr
27. Requip Lp
28. Requip Pr
29. Requip Xr
30. Skf-101468a
31. Mfcd01754173
32. Requip (tn)
33. 1,3-dihydro-4-(2-(dipropylamino)ethyl)-2h-indol-2-one Monohydrochloride
34. Jzp-7
35. Schembl40760
36. Mls003899234
37. Chebi:8889
38. Chembl1200411
39. Hy-b0623a
40. Dtxsid50238533
41. Nvd-434
42. 4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one Hydrochloride
43. Act02690
44. Bcp02130
45. Ex-a4943
46. Ropinirole For Peak Identification 1
47. Ropinirole For Peak Identification 2
48. Ropinirole For Peak Identification 3
49. Ropinirole Hydrochloride (jan/usp)
50. Tox21_501101
51. Ac-735
52. Ac-736
53. Np-201
54. Ropinirole Hydrochloride [mi]
55. S3189
56. Ropinirole Hydrochloride [jan]
57. Akos015844988
58. Bs-1020
59. Ccg-213346
60. Hp-3000
61. Lp01101
62. 2(h)-indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, Monohydrochloride
63. Ropinirole Hydrochloride [mart.]
64. Ropinirole Hydrochloride [vandf]
65. Ncgc00094373-01
66. Ncgc00261786-01
67. Ropinirole Hydrochloride [usp-rs]
68. Ropinirole Hydrochloride [who-dd]
69. Smr001456484
70. Eu-0101101
71. Ft-0642200
72. Sw199044-2
73. Ropinirole Hydrochloride [orange Book]
74. D00784
75. R 4152
76. Ropinirole Hydrochloride [ep Monograph]
77. Ropinirole Hydrochloride [usp Monograph]
78. 374r208
79. A843815
80. Ropinirole Hydrochloride, Powder, >=98% (hplc)
81. Sr-01000076215-2
82. Sr-01000076215-5
83. 4-(2-dipropylamino-ethyl)-1,3-dihydro-indol-2-one
84. Q27276228
85. 4-(2-di-n-propylaminoethyl)-2(3h)indolone Hydrochloride
86. Z1695926158
87. 4-(2-di-n-propylaminoethyl)-2(3h)-indolone Hydrochloride
88. 4-[2-(dipropylamino)ethyl]-1,3-dihy Dro-2h-indol-2-one Hydrochloride
89. 4-[2-(dipropylamino)ethyl]-2,3-dihydro-1h-indol-2-one Hydrochloride
90. Ropinirole Hydrochloride, Europepharmacopoeia (ep) Reference Standard
91. 2h-indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-, Monohydrochloride
92. 4-(2-(dipropylamino)ethyl)-1,3-dihydro-2h-indol-2-one Monohydrochloride
93. Ropinirole For Peak Identification 1, Europepharmacopoeia (ep) Reference Standard
94. Ropinirole For Peak Identification 2, Europepharmacopoeia (ep) Reference Standard
95. Ropinirole Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
96. Ropinirole Hydrochloride, United States Pharmacopeia (usp) Reference Standard
97. Skf 101468; 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2h-indol-2-one Hydrochloride
Molecular Weight | 296.83 g/mol |
---|---|
Molecular Formula | C16H25ClN2O |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 2 |
Rotatable Bond Count | 7 |
Exact Mass | 296.1655411 g/mol |
Monoisotopic Mass | 296.1655411 g/mol |
Topological Polar Surface Area | 32.3 Ų |
Heavy Atom Count | 20 |
Formal Charge | 0 |
Complexity | 287 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Ropinirole hydrochloride |
Drug Label | Ropinirole hydrochloride is an orally administered non-ergoline dopamine agonist. It is the hydrochloride salt of 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one monohydrochloride and has an molecular formula of C16H24N2OHCl. The molecular w... |
Active Ingredient | Ropinirole hydrochloride |
Dosage Form | Tablet, extended release; Tablet |
Route | Oral |
Strength | eq 4mg base; eq 5mg base; eq 0.5mg base; eq 2mg base; eq 0.25mg base; eq 6mg base; eq 1mg base; eq 12mg base; eq 3mg base; eq 8mg base |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Alembic; Teva; Apotex; Sandoz; Prinston; Roxane; Watson Labs; Glenmark Generics; Actavis Elizabeth; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan |
2 of 2 | |
---|---|
Drug Name | Ropinirole hydrochloride |
Drug Label | Ropinirole hydrochloride is an orally administered non-ergoline dopamine agonist. It is the hydrochloride salt of 4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one monohydrochloride and has an molecular formula of C16H24N2OHCl. The molecular w... |
Active Ingredient | Ropinirole hydrochloride |
Dosage Form | Tablet, extended release; Tablet |
Route | Oral |
Strength | eq 4mg base; eq 5mg base; eq 0.5mg base; eq 2mg base; eq 0.25mg base; eq 6mg base; eq 1mg base; eq 12mg base; eq 3mg base; eq 8mg base |
Market Status | Prescription |
Company | Mylan Pharms; Wockhardt; Alembic; Teva; Apotex; Sandoz; Prinston; Roxane; Watson Labs; Glenmark Generics; Actavis Elizabeth; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan |
Induction of vomiting in dogs.
Antiparkinson Agents
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. (See all compounds classified as Antiparkinson Agents.)
Dopamine Agonists
Drugs that bind to and activate dopamine receptors. (See all compounds classified as Dopamine Agonists.)
QN04BC04
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
A Ropinirole Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ropinirole Hydrochloride, including repackagers and relabelers. The FDA regulates Ropinirole Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ropinirole Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Ropinirole Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Ropinirole Hydrochloride supplier is an individual or a company that provides Ropinirole Hydrochloride active pharmaceutical ingredient (API) or Ropinirole Hydrochloride finished formulations upon request. The Ropinirole Hydrochloride suppliers may include Ropinirole Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Ropinirole Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Ropinirole Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Ropinirole Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Ropinirole Hydrochloride DMFs exist exist since differing nations have different regulations, such as Ropinirole Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Ropinirole Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Ropinirole Hydrochloride USDMF includes data on Ropinirole Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ropinirole Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Ropinirole Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Ropinirole Hydrochloride Drug Master File in Japan (Ropinirole Hydrochloride JDMF) empowers Ropinirole Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Ropinirole Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Ropinirole Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Ropinirole Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ropinirole Hydrochloride Drug Master File in Korea (Ropinirole Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ropinirole Hydrochloride. The MFDS reviews the Ropinirole Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Ropinirole Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ropinirole Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ropinirole Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ropinirole Hydrochloride suppliers with KDMF on PharmaCompass.
A Ropinirole Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Ropinirole Hydrochloride Certificate of Suitability (COS). The purpose of a Ropinirole Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ropinirole Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ropinirole Hydrochloride to their clients by showing that a Ropinirole Hydrochloride CEP has been issued for it. The manufacturer submits a Ropinirole Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ropinirole Hydrochloride CEP holder for the record. Additionally, the data presented in the Ropinirole Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ropinirole Hydrochloride DMF.
A Ropinirole Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ropinirole Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Ropinirole Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Ropinirole Hydrochloride written confirmation (Ropinirole Hydrochloride WC) is an official document issued by a regulatory agency to a Ropinirole Hydrochloride manufacturer, verifying that the manufacturing facility of a Ropinirole Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Ropinirole Hydrochloride APIs or Ropinirole Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Ropinirole Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Ropinirole Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ropinirole Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Ropinirole Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Ropinirole Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Ropinirole Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ropinirole Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Ropinirole Hydrochloride suppliers with NDC on PharmaCompass.
Ropinirole Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Ropinirole Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ropinirole Hydrochloride GMP manufacturer or Ropinirole Hydrochloride GMP API supplier for your needs.
A Ropinirole Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Ropinirole Hydrochloride's compliance with Ropinirole Hydrochloride specifications and serves as a tool for batch-level quality control.
Ropinirole Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Ropinirole Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Ropinirole Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Ropinirole Hydrochloride EP), Ropinirole Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ropinirole Hydrochloride USP).
LOOKING FOR A SUPPLIER?